Sec Form 13D Filing - Atlas Venture Fund X L.P. filing for Replimune Group Inc. (REPL) - 2022-12-06

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13D/A

Under the Securities Exchange Act of 1934

(Amendment No. 5)*

REPLIMUNE GROUP, INC.

(Name of Issuer)

Common Stock, $0.001 par value per share

(Title of Class of Securities)

76029N106

(CUSIP Number)

Atlas Venture

Attention: Ommer Chohan, Chief Financial Officer

300 Technology Square, 8th Floor

Cambridge, MA 02139 USA

(857) 201-2700

(Name, Address and Telephone Number of Person Authorized to

Receive Notices and Communications)

November 23, 2022

(Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.

* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

  

 

 

CUSIP 76029N106 Page 2 of 9

 

1  

NAMES OF REPORTING PERSONS:

ATLAS VENTURE FUND X, L.P.

2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS):

(a) (b)

3   SEC USE ONLY:
4  

SOURCE OF FUNDS (SEE INSTRUCTIONS):

WC

5  

CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e):

6  

CITIZENSHIP OR PLACE OF ORGANIZATION:

Delaware

NUMBER
OF SHARES
BENEFICIALLY
OWNED
BY EACH
REPORTING
PERSON WITH
  7  

SOLE VOTING POWER:

0

  8  

SHARED VOTING POWER:

1,498,6351

  9  

SOLE DISPOSITIVE POWER:

0

  10  

SHARED DISPOSITIVE POWER:

1,498,6351

11  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:

1,498,6351

12  

CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS):

13  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11):

3.0%2

14  

TYPE OF REPORTING PERSON (SEE INSTRUCTIONS):

PN

 

  1 As described in Item 5 below, Atlas Venture Fund X, L.P., a Delaware limited partnership (“Atlas X”), Atlas Venture Associates X, L.P., a Delaware limited partnership (“AVA X LP”) and Atlas Venture Associates X, LLC, a Delaware limited liability company (“AVA X LLC” and together with Atlas X and AVA X LP, the “Fund X Reporting Persons”) beneficially own the 1,498,635 shares of the Issuer’s Common Stock that are directly held by Atlas X. AVA X LP is the general partner of Atlas X and AVA X LLC is the general partner of AVA X LP. Each of AVA X LP and AVA X LLC has voting and dispositive power over the shares held by Atlas X. As such, each of the Fund X Reporting Persons share voting and dispositive power with respect to the shares held by Atlas X.

 

  2 This percentage is calculated based upon 49,739,407 outstanding shares of Common Stock of the Issuer as of October 31, 2022, as reported in the Issuer’s Quarterly Report on Form 10-Q, filed with the Securities and Exchange Commission on November 3, 2022.

 

  

 

CUSIP 76029N106 Page 3 of 9

 

1  

NAMES OF REPORTING PERSONS:

ATLAS VENTURE ASSOCIATES X, L.P.

2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS):

(a) (b)

3   SEC USE ONLY:
4  

SOURCE OF FUNDS (SEE INSTRUCTIONS):

AF

5  

CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e):

6  

CITIZENSHIP OR PLACE OF ORGANIZATION:

Delaware

NUMBER
OF SHARES
BENEFICIALLY
OWNED
BY EACH
REPORTING
PERSON WITH
  7  

SOLE VOTING POWER:

0

  8  

SHARED VOTING POWER:

1,498,6351

  9  

SOLE DISPOSITIVE POWER:

0

  10  

SHARED DISPOSITIVE POWER:

1,498,6351

11  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:

1,498,6351

12  

CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS):

13  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11):

3.0%2

14  

TYPE OF REPORTING PERSON (SEE INSTRUCTIONS):

PN

 

  1 As described in Item 5 below, Atlas Venture Associates X, L.P., a Delaware limited partnership (“AVA X LP”) and Atlas Venture Associates X, LLC, a Delaware limited liability company (“AVA X LLC”) beneficially own 1,498,635 shares of the Issuer’s Common Stock. All of these shares are directly held by Atlas Venture Fund X, L.P., a Delaware limited partnership (“Atlas X”). AVA X LP is the general partner of Atlas X and AVA X LLC is the general partner of AVA X LP. AVA X LLC has voting and dispositive power over the shares held by each of Atlas X and AVA X LP and AVA X LP has voting and dispositive power over the shares held by Atlas X. As such, each of Atlas X, AVA X LP and AVA X LLC share voting and dispositive power with respect to the shares held by Atlas X.

 

  2 This percentage is calculated based upon 49,739,407 outstanding shares of Common Stock of the Issuer as of October 31, 2022, as reported in the Issuer’s Quarterly Report on Form 10-Q, filed with the Securities and Exchange Commission on November 3, 2022.

 

  

 

CUSIP 76029N106 Page 4 of 9

 

1  

NAMES OF REPORTING PERSONS:

Atlas Venture Associates X, LLC

2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS):

(a) (b)

3   SEC USE ONLY:
4  

SOURCE OF FUNDS (SEE INSTRUCTIONS):

AF

5  

CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e):

6  

CITIZENSHIP OR PLACE OF ORGANIZATION:

Delaware

NUMBER
OF SHARES
BENEFICIALLY
OWNED
BY EACH
REPORTING
PERSON WITH
  7  

SOLE VOTING POWER:

0

  8  

SHARED VOTING POWER:

1,498,6351

  9  

SOLE DISPOSITIVE POWER:

0

  10  

SHARED DISPOSITIVE POWER:

1,498,6351

11  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:

1,498,6351

12  

CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS):

13  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11):

3.0%2

14  

TYPE OF REPORTING PERSON (SEE INSTRUCTIONS):

OO

 

1 As described in Item 5 below, Atlas Venture Associates X, L.P., a Delaware limited partnership (“AVA X LP”) and Atlas Venture Associates X, LLC, a Delaware limited liability company (“AVA X LLC”) beneficially own 1,498,635 shares of the Issuer’s Common Stock. All of these shares are directly held by Atlas Venture Fund X, L.P., a Delaware limited partnership (“Atlas X”). AVA X LP is the general partner of Atlas X and AVA X LLC is the general partner of AVA X LP. AVA X LLC has voting and dispositive power over the shares held by each of Atlas X and AVA X LP and AVA X LP has voting and dispositive power over the shares held by Atlas X. As such, each of Atlas X, AVA X LP and AVA X LLC share voting and dispositive power with respect to the shares held by Atlas X.

 

2 This percentage is calculated based upon 49,739,407 outstanding shares of Common Stock of the Issuer as of October 31, 2022, as reported in the Issuer’s Quarterly Report on Form 10-Q, filed with the Securities and Exchange Commission on November 3, 2022.

 

  

 

CUSIP 76029N106 Page 5 of 9

 

1  

NAMES OF REPORTING PERSONS:

Atlas Venture Opportunity Fund I, L.P.

2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS):

(a) (b)

3   SEC USE ONLY:
4  

SOURCE OF FUNDS (SEE INSTRUCTIONS):

WC

5  

CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e):

6  

CITIZENSHIP OR PLACE OF ORGANIZATION:

Delaware

NUMBER
OF SHARES
BENEFICIALLY
OWNED
BY EACH
REPORTING
PERSON WITH
  7  

SOLE VOTING POWER:

0

  8  

SHARED VOTING POWER:

946,0001

  9  

SOLE DISPOSITIVE POWER:

0

  10  

SHARED DISPOSITIVE POWER:

946,0001

11  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:

946,0001

12  

CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS):

13  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11):

1.9%2

14  

TYPE OF REPORTING PERSON (SEE INSTRUCTIONS):

PN

 

  1 As described in Item 5 below, Atlas Venture Opportunity Fund I, L.P., a Delaware limited partnership (“AVOF”), Atlas Venture Associates Opportunity I, L.P., a Delaware limited partnership (“AVAO LP”) and Atlas Venture Associates Opportunity I, LLC, a Delaware limited liability company (“AVAO LLC” and together with AVOF and AVAO LP, the “Opportunity Fund Reporting Persons”) beneficially own 946,000 shares of the Issuer’s Common Stock. All of these shares are held by AVOF. AVAO LP is the general partner of AVOF and AVAO LLC is the general partner of AVAO LP.  Each of AVAO LP and AVAO LLC has voting and dispositive power over the shares held by AVOF. As such, each of the Opportunity Fund Reporting Persons share voting and dispositive power with respect to the shares held by AVOF.

 

  2 This percentage is calculated based upon 49,739,407 outstanding shares of Common Stock of the Issuer as of October 31, 2022, as reported in the Issuer’s Quarterly Report on Form 10-Q, filed with the Securities and Exchange Commission on November 3, 2022.

 

  

 

CUSIP 76029N106 Page 6 of 9

 

1  

NAMES OF REPORTING PERSONS:

Atlas Venture Associates Opportunity I, L.P.

2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS):

(a) (b)

3   SEC USE ONLY:
4  

SOURCE OF FUNDS (SEE INSTRUCTIONS):

AF

5  

CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e):

6  

CITIZENSHIP OR PLACE OF ORGANIZATION:

Delaware

NUMBER
OF SHARES
BENEFICIALLY
OWNED
BY EACH
REPORTING
PERSON WITH
  7  

SOLE VOTING POWER:

0

  8  

SHARED VOTING POWER:

946,0001

  9  

SOLE DISPOSITIVE POWER:

0

  10  

SHARED DISPOSITIVE POWER:

946,0001

11  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:

946,0001

12  

CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS):

13  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11):

1.9%2

14  

TYPE OF REPORTING PERSON (SEE INSTRUCTI ONS):

PN

 

  1 As described in Item 5 below, Atlas Venture Opportunity Fund I, L.P., a Delaware limited partnership (“AVOF”), Atlas Venture Associates Opportunity I, L.P., a Delaware limited partnership (“AVAO LP”) and Atlas Venture Associates Opportunity I, LLC, a Delaware limited liability company (“AVAO LLC” and together with AVOF and AVAO LP, the “Opportunity Fund Reporting Persons”) beneficially own 946,000 shares of the Issuer’s Common Stock. All of these shares are held by AVOF. AVAO LP is the general partner of AVOF and AVAO LLC is the general partner of AVAO LP.  Each of AVAO LP and AVAO LLC has voting and dispositive power over the shares held by AVOF. As such, each of the Opportunity Fund Reporting Persons share voting and dispositive power with respect to the shares held by AVOF.

 

  2 This percentage is calculated based upon 49,739,407 outstanding shares of Common Stock of the Issuer as of October 31, 2022, as reported in the Issuer’s Quarterly Report on Form 10-Q, filed with the Securities and Exchange Commission on November 3, 2022.

 

  

 

CUSIP 76029N106 Page 7 of 9

 

1  

NAMES OF REPORTING PERSONS:

Atlas Venture Associates Opportunity I, LLC

2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS):

(a) (b)

3   SEC USE ONLY:
4  

SOURCE OF FUNDS (SEE INSTRUCTIONS):

AF

5  

CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e):

6  

CITIZENSHIP OR PLACE OF ORGANIZATION:

Delaware

NUMBER
OF SHARES
BENEFICIALLY
OWNED
BY EACH
REPORTING
PERSON WITH
  7  

SOLE VOTING POWER:

0

  8  

SHARED VOTING POWER:

946,0001

  9  

SOLE DISPOSITIVE POWER:

0

  10  

SHARED DISPOSITIVE POWER:

946,0001

11  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:

946,0001

12  

CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS):

13  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11):

1.9%2

14  

TYPE OF REPORTING PERSON (SEE INSTRUCTIONS):

OO

 

  1 As described in Item 5 below, Atlas Venture Opportunity Fund I, L.P., a Delaware limited partnership (“AVOF”), Atlas Venture Associates Opportunity I, L.P., a Delaware limited partnership (“AVAO LP”) and Atlas Venture Associates Opportunity I, LLC, a Delaware limited liability company (“AVAO LLC” and together with AVOF and AVAO LP, the “Opportunity Fund Reporting Persons”) beneficially own 946,000 shares of the Issuer’s Common Stock. All of these shares are held by AVOF. AVAO LP is the general partner of AVOF and AVAO LLC is the general partner of AVAO LP.  Each of AVAO LP and AVAO LLC has voting and dispositive power over the shares held by AVOF. As such, each of the Opportunity Fund Reporting Persons share voting and dispositive power with respect to the shares held by AVOF.

 

  2 This percentage is calculated based upon 49,739,407 outstanding shares of Common Stock of the Issuer as of October 31, as reported in the Issuer’s Quarterly Report on Form 10-Q, filed with the Securities and Exchange Commission on November 3, 2022.

 

  

 

CUSIP 76029N106   Page 8 of 9

INTRODUCTION

This Amendment No. 5 to Schedule 13D (“Amendment No. 4”) is being filed as an amendment to the statement on Schedule 13D relating to common stock, par value $0.001 per share (the “Common Stock”) of Replimune Group, Inc., a Delaware corporation (the “Issuer” or “Replimune”), as filed with the Securities and Exchange Commission (the “SEC”) on November 11, 2019, amended by Amendment No.1 to the Prior Schedule 13D, as filed with the SEC on June 19, 2020, amended by Amendment No.2 to the Prior Schedule 13D, as filed with the SEC on July 7, 2020, amended by Amendment No.3 to the Prior Schedule 13D, as filed with the SEC on September 17, 2020, and amended by Amendment No.4 to the Prior Schedule 13D, as filed with the SEC on September 14, 2022 (together, the “Prior Schedule 13D”). All capitalized terms not otherwise defined herein shall have the meanings ascribed to the terms in the Prior Schedule 13D. The Prior Schedule 13D is hereby amended and supplemented as follows and, except as expressly amended below, the Prior Schedule 13D remains in full force and effect.

ITEM 5. INTEREST IN SECURITIES OF THE ISSUER

(a)(b) As of November 29, 2022, Atlas X is the record owner of 1,498,635 shares of Common Stock. AVA X LP is the general partner of Atlas X and AVA X LLC is the general partner of AVA X LP. Each of Atlas X, AVA X LP and AVA X LLC has shared voting and dispositive power over the shares held by Atlas X. As such, each of Atlas X, AVA X LP and AVA X LLC may be deemed to beneficially own the shares held by Atlas X.

As of November 29, 2022, AVOF is the record owner of 946,000 shares of Common Stock. AVAO LP is the general partner of AVOF and AVAO LLC is the general partner of AVAO LP. Each of AVOF, AVAO LP and AVAO LLC has shared voting and dispositive power over the shares held by AVOF. As such, each of AVOF, AVAO LP and AVAO LLC may be deemed to beneficially own the shares held by AVOF.

Each of the Fund X Reporting Persons and Opportunity Fund Reporting Persons may be deemed to beneficially own 3.0% and 1.9%, respectively, of the Issuer’s outstanding Common Stock, which percentages are calculated based upon 49,739,407 outstanding shares of Common Stock of the Issuer as of October 31, 2022, as reported in the Issuer’s Quarterly Report on Form 10-Q, filed with the Securities and Exchange Commission on November 3, 2022.

Collectively, the Reporting Persons beneficially own an aggregate of 2,444,635 shares of Common Stock, which represents 4.9% of the Issuer's outstanding Common Stock. The Fund X Reporting Persons and the Opportunity Fund Reporting Persons are under common control and as a result, the Reporting Persons may be deemed to be members of a group. However, the Reporting Persons disclaim such group membership, and this Schedule 13D shall not be deemed an admission that the Reporting Persons are members of a group for purposes of Section 13 or for any other purposes.

 

(c) The transactions in the Common Stock by the Reporting Persons during the past sixty days are set forth on Schedule A and are incorporated herein by reference. Except for the foregoing, no Reporting Person has engaged in any transactions in the Common Stock in the sixty days preceding the date hereof.

 

(d) No other person is known by the Reporting Persons to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the shares of Common Stock beneficially owned by the Reporting Persons.
   
(e) The Reporting Persons ceased to be the beneficial owners of more than five percent of the Common Stock on November 29, 2022.

 

  

 

CUSIP 76029N106 Page 9 of 9

SIGNATURES

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: December 6, 2022

ATLAS VENTURE FUND X, L.P.
 
By: Atlas Venture Associates X, L.P., its general partner
By: Atlas Venture Associates X, LLC, its general partner
     
By: /s/ Ommer Chohan  
Name: Ommer Chohan  
Title: Chief Financial Officer  
     
ATLAS VENTURE ASSOCIATES X, L.P.
     
By: Atlas Venture Associates X, LLC, its general partner
     
By: /s/ Ommer Chohan  
Name: Ommer Chohan  
Title: Chief Financial Officer  
     
ATLAS VENTURE ASSOCIATES X, LLC
     
By: /s/ Ommer Chohan  
Name: Ommer Chohan  
Title: Chief Financial Officer  
     
ATLAS VENTURE OPPORTUNITY FUND I, L.P.
     
By: Atlas Venture Associates Opportunity I, L.P., its general partner
By: Atlas Venture Associates Opportunity I, LLC, its general partner
     
By: /s/ Ommer Chohan  
Name: Ommer Chohan  
Title: Chief Financial Officer  
     
ATLAS VENTURE ASSOCIATES OPPORTUNITY I, L.P.
     
By: Atlas Venture Associates Opportunity I, LLC, its general partner
     
By: /s/ Ommer Chohan  
Name: Ommer Chohan  
Title: Chief Financial Officer  
     
ATLAS VENTURE ASSOCIATES OPPORTUNITY I, LLC
     
By: /s/ Ommer Chohan  
Name: Ommer Chohan  
Title: Chief Financial Officer  


  

 

 

SCHEDULE A

 

Sales During the Past Sixty Days

 

Atlas Venture Fund X, LP

 

 

Date of Sale

Number of

Shares Sold

Weighted Average

Price/Share

Low Price High Price
October 7, 2022 6,915 $17.37 $17.30 $17.55
October 10, 2022 3,734 $17.35 $17.30 $17.37
October 11, 2022 70,841 $17.70 $17.05 $18.11
October 12, 2022 22,954 $17.76 $17.49 $17.95
October 13, 2022 19,571 $17.76 $17.51 $17.87
October 14, 2022 68,719 $18.75 $18.08 $19.07
October 17, 2022 38,323 $18.74 $18.11 $19.28
October 18, 2022 27,581 $19.06 $18.60 $19.39
October 19, 2022 6,039 $17.96 $17.50 $18.62
October 20, 2022 24,569 $17.73 $17.50 $17.89
October 21, 2022 10,754 $17.90 $17.56 $18.39
November 2, 2022 1,557 $20.13 $20.00 $20.20
November 3, 2022 1,931 $20.02 $20.01 $20.06
November 10, 2022 7,704 $20.11 $20.01 $20.20
November 11, 2022 20,379 $20.90 $20.08 $21.26
November 14, 2022 45,357 $20.74 $20.12 $21.17
November 15, 2022 23,395 $20.00 $19.50 $21.21
November 16, 2022 800 $19.55 $19.51 $19.60
November 17, 2022 12,686 $19.51 $19.50 $19.54
November 18, 2022 3,200 $19.67 $19.50 $19.99
November 22, 2022 3,838 $19.74 $19.50 $19.84
November 23, 2022 112,453 $19.42 $19.40 $19.86
November 25, 2022 28,252 $19.89 $19.50 $20.05
November 28, 2022 20,020 $19.75 $19.50 $20.24
November 29, 2022 82,093 $19.53 $19.50 $19.76